Utility of a Multiparametric Quantitative MRI Model That Assesses Myelin and Edema for Evaluating Plaques, Periplaque White Matter, and Normal-Appearing White Matter in Patients with Multiple Sclerosis: A Feasibility Study

References

1. 1.↵
   2. Polman CH,
   3. Reingold SC,
   4. Banwell B, et al

   . Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69:292–302 doi:10.1002/ana.22366 pmid:21387374

   CrossRefPubMedWeb of Science
2. 2.↵
   2. Filippi M,
   3. Rocca MA,
   4. De Stefano N, et al

   . Magnetic resonance techniques in multiple sclerosis: the present and the future. Arch Neurol 2011;68:1514–20 doi:10.1001/archneurol.2011.914 pmid:22159052

   CrossRefPubMed
3. 3.↵
   2. Giorgio A,
   3. De Stefano N

   . Advanced structural and functional brain MRI in multiple sclerosis. Semin Neurol 2016;36:163–76 doi:10.1055/s-0036-1579737 pmid:27116723

   CrossRefPubMed
4. 4.↵
   2. Guo AC,
   3. MacFall JR,
   4. Provenzale JM

   . Multiple sclerosis: diffusion tensor MR imaging for evaluation of normal-appearing white matter. Radiology 2002;222:729–36 doi:10.1148/radiol.2223010311 pmid:11867792

   CrossRefPubMedWeb of Science
5. 5.↵
   2. Hori M,
   3. Yoshida M,
   4. Yokoyama K, et al

   . Multiple sclerosis: benefits of q-space imaging in evaluation of normal-appearing and periplaque white matter. Magn Reson Imaging 2014;32:625–29 doi:10.1016/j.mri.2014.02.024 pmid:24726649

   CrossRefPubMed
6. 6.↵
   2. Warntjes JB,
   3. Leinhard OD,
   4. West J, et al

   . Rapid magnetic resonance quantification on the brain: optimization for clinical usage. Magn Reson Med 2008;60:320–29 doi:10.1002/mrm.21635 pmid:18666127

   CrossRefPubMed
7. 7.↵
   2. Krauss W,
   3. Gunnarsson M,
   4. Andersson T, et al

   . Accuracy and reproducibility of a quantitative magnetic resonance imaging method for concurrent measurements of tissue relaxation times and proton density. Magn Reson Imaging 2015;33:584–91 doi:10.1016/j.mri.2015.02.013 pmid:25708264

   CrossRefPubMed
8. 8.↵
   2. Hagiwara A,
   3. Hori M,
   4. Suzuki M, et al

   . Contrast-enhanced synthetic MRI for the detection of brain metastases. Acta Radiol Open 2016;5:2058460115626757 doi:10.1177/2058460115626757 pmid:26962461

   Abstract/FREE Full Text
9. 9.↵
   2. Hagiwara A,
   3. Nakazawa M,
   4. Andica C, et al

   . Dural enhancement in a patient with Sturge-Weber syndrome revealed by double inversion recovery contrast using synthetic MRI. Magn Reson Med Sci 2016;15:151–52 doi:10.2463/mrms.ci.2015-0066 pmid:26549162

   CrossRefPubMed
10. 10.↵
    2. Andica C,
    3. Hagiwara A,
    4. Nakazawa M, et al

    . The advantage of synthetic MRI for the visualization of early white matter change in an infant with Sturge-Weber syndrome. Magn Reson Med Sci 2016 Mar 21. [Epub ahead of print] pmid:27001386

    CrossRefPubMed
11. 11.↵
    2. Granberg T,
    3. Uppman M,
    4. Hashim F, et al

    . Clinical feasibility of synthetic MRI in multiple sclerosis: a diagnostic and volumetric validation study. AJNR Am J Neuroradiol 2016;37:1023–29 doi:10.3174/ajnr.A4665 pmid:26797137

    Abstract/FREE Full Text
12. 12.↵
    2. West J,
    3. Aalto A,
    4. Tisell A, et al

    . Normal appearing and diffusely abnormal white matter in patients with multiple sclerosis assessed with quantitative MR. PLoS One 2014;9:e95161 doi:10.1371/journal.pone.0095161 pmid:24747946

    CrossRefPubMed
13. 13.↵
    2. Warntjes M,
    3. Engström M,
    4. Tisell A, et al

    . Modeling the presence of myelin and edema in the brain based on multi-parametric quantitative MRI. Front Neurol 2016;7:16 doi:10.3389/fneur.2016.00016 pmid:26925030

    CrossRefPubMed
14. 14.↵
    2. Bjarnason TA,
    3. Vavasour IM,
    4. Chia CL, et al

    . Characterization of the NMR behavior of white matter in bovine brain. Magn Reson Med 2005;54:1072–81 doi:10.1002/mrm.20680 pmid:16200557

    CrossRefPubMed
15. 15.↵
    2. Laule C,
    3. Leung E,
    4. Lis DK, et al

    . Myelin water imaging in multiple sclerosis: quantitative correlations with histopathology. Mult Scler 2006;12:747–53 doi:10.1177/1352458506070928 pmid:17263002

    Abstract/FREE Full Text
16. 16.↵
    2. McDonald WI,
    3. Compston A,
    4. Edan G, et al

    . Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001;50:121–27 doi:10.1002/ana.1032 pmid:11456302

    CrossRefPubMedWeb of Science
17. 17.↵
    2. Polman CH,
    3. Reingold SC,
    4. Edan G, et al

    . Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria.” Ann Neurol 2005;58:840–46 doi:10.1002/ana.20703 pmid:16283615

    CrossRefPubMedWeb of Science
18. 18.↵
    2. Seewann A,
    3. Vrenken H,
    4. van der Valk P, et al

    . Diffusely abnormal white matter in chronic multiple sclerosis: imaging and histopathologic analysis. Arch Neurol 2009;66:601–09 pmid:19433660

    CrossRefPubMedWeb of Science
19. 19.↵
    2. Kurtzke JF

    . A new scale for evaluating disability in multiple sclerosis. Neurology 1955;5:580–83 doi:10.1212/WNL.5.8.580 pmid:13244774

    FREE Full Text
20. 20.↵
    2. Nijeholt GJ,
    3. Bergers E,
    4. Kamphorst W, et al

    . Post-mortem high-resolution MRI of the spinal cord in multiple sclerosis: a correlative study with conventional MRI, histopathology and clinical phenotype. Brain 2001;124:154–66 doi:10.1093/brain/124.1.154 pmid:11133795

    Abstract/FREE Full Text
21. 21.↵
    2. Lieury A,
    3. Chanal M,
    4. Androdias G, et al

    . Tissue remodeling in periplaque regions of multiple sclerosis spinal cord lesions. Glia 2014;62:1645–58 doi:10.1002/glia.22705 pmid:24910450

    CrossRefPubMed
22. 22.↵
    2. Narayanan S,
    3. Fu L,
    4. Pioro E, et al

    . Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions. Ann Neurol 1997;41:385–91 doi:10.1002/ana.410410314 pmid:9066360

    CrossRefPubMedWeb of Science
23. 23.↵
    2. Perry VH,
    3. Anthony DC

    . Axon damage and repair in multiple sclerosis. Philos Trans R Soc Lond B Biol Sci 1999;354:1641–47 doi:10.1098/rstb.1999.0509 pmid:10603617

    Abstract/FREE Full Text
24. 24.↵
    2. Dziedzic T,
    3. Metz I,
    4. Dallenga T, et al

    . Wallerian degeneration: a major component of early axonal pathology in multiple sclerosis. Brain Pathol 2010;20:976–85 doi:10.1111/j.1750-3639.2010.00401.x pmid:20477831

    CrossRefPubMedWeb of Science
25. 25.↵
    2. Simons M,
    3. Misgeld T,
    4. Kerschensteiner M

    . A unified cell biological perspective on axon-myelin injury. J Cell Biol 2014;206:335–45 doi:10.1083/jcb.201404154 pmid:20477831

    Abstract/FREE Full Text
26. 26.↵
    2. McDonald WI,
    3. Miller DH,
    4. Barnes D

    . The pathological evolution of multiple sclerosis. Neuropathol Appl Neurobiol 1992;18:319–34 doi:10.1111/j.1365-2990.1992.tb00794.x pmid:1528388

    CrossRefPubMedWeb of Science
27. 27.↵
    2. Helms G,
    3. Stawiarz L,
    4. Kivisakk P, et al

    . Regression analysis of metabolite concentrations estimated from localized proton MR spectra of active and chronic multiple sclerosis lesions. Magn Reson Med 2000;43:102–10 pmid:10642736

    CrossRefPubMedWeb of Science
28. 28.↵
    2. Brosnan CF,
    3. Raine CS

    . The astrocyte in multiple sclerosis revisited. Glia 2013;61:453–65 doi:10.1002/glia.22443 pmid:23322421

    CrossRefPubMedWeb of Science
29. 29.↵
    2. Blystad I,
    3. Hakansson I,
    4. Tisell A, et al

    . Quantitative MRI for analysis of active multiple sclerosis lesions without gadolinium-based contrast agent. AJNR Am J Neuroradiol 2016;37:94–100 doi:10.3174/ajnr.A4501 pmid:26471751

    Abstract/FREE Full Text
30. 30.↵
    2. Kolind S,
    3. Matthews L,
    4. Johansen-Berg H, et al

    . Myelin water imaging reflects clinical variability in multiple sclerosis. Neuroimage 2012;60:263–70 doi:10.1016/j.neuroimage.2011.11.070 pmid:22155325

    CrossRefPubMed
31. 31.↵
    2. Faizy TD,
    3. Thaler C,
    4. Kumar D, et al

    . Heterogeneity of multiple sclerosis lesions in multislice myelin water imaging. PLoS One 2016;11:e0151496 doi:10.1371/journal.pone.0151496 pmid:26990645

    CrossRefPubMed
32. 32.↵
    2. Zhang H,
    3. Schneider T,
    4. Wheeler-Kingshott CA, et al

    . NODDI: practical in vivo neurite orientation dispersion and density imaging of the human brain. Neuroimage 2012;61:1000–16 doi:10.1016/j.neuroimage.2012.03.072 pmid:22484410

    CrossRefPubMed
33. 33.↵
    2. Stikov N,
    3. Campbell JS,
    4. Stroh T, et al

    . In vivo histology of the myelin g-ratio with magnetic resonance imaging. Neuroimage 2015;118:397–405 doi:10.1016/j.neuroimage.2015.05.023 pmid:26004502

    CrossRefPubMed